Vincenzo Armentano

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study

Maria Chiara Rossi, Antonio Nicolucci, Alessandro Ozzello et al. · Nutrition Metabolism and Cardiovascular Diseases · 2019 · 123 citations

Medicine, Endocrinology, Internal Medicine +11

Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study

Carlo Giorda, Maria Chiara Rossi, O. Ozzello et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 38 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +14

Unexplained Hypoglycaemia and Large Glycaemic Variability: Skin Lipohypertrophy as a Predictive Sign

Felice Strollo, Giuseppina Guarino, Vincenzo Armentano et al. · Diabetes Research - Open Journal · 2016 · 27 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Personalizing Treatment in Type 2 Diabetes: A Self-Monitoring of Blood Glucose Inclusive Innovative Approach

Antonio Ceriello, Marco Gallo, Vincenzo Armentano et al. · Diabetes Technology & Therapeutics · 2012 · 26 citations

Medicine, Endocrinology, Health Informatics +17